|
gptkbp:instanceOf
|
gptkb:drug
sulfonylurea
|
|
gptkbp:ATCCode
|
A10BB09
|
|
gptkbp:brand
|
gptkb:Diamicron
Diamicron MR
Diaprel
Glyade
Zicron
|
|
gptkbp:CASNumber
|
21187-98-4
|
|
gptkbp:contraindication
|
gptkb:diabetic_ketoacidosis
type 1 diabetes
|
|
gptkbp:discoveredBy
|
gptkb:Servier
|
|
gptkbp:eliminationHalfLife
|
10-12 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasMolecularFormula
|
C15H21N3O3S
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Gliclazide
|
|
gptkbp:introducedIn
|
1973
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
stimulates insulin secretion
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
gptkb:C_(Australia)
C (US)
|
|
gptkbp:proteinBinding
|
85-99%
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gptkb:hypoglycemia
weight gain
gastrointestinal disturbance
|
|
gptkbp:synonym
|
N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide
|
|
gptkbp:usedFor
|
gptkb:type_2_diabetes_mellitus
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
included
|
|
gptkbp:bfsParent
|
gptkb:Zentiva
|
|
gptkbp:bfsLayer
|
7
|